Please wait while the formulary information is being retrieved.
BEXSERO (MENINGOCOCCAL GROUP B VACCINE, 4-COMPONENT)
- Meningococcal vaccination
50 mcg-50 mcg-50 mcg-25 mcg/0.5 mL intramuscular syringe
- Inject 0.5 milliliter by intramuscular route once
50 mcg-50 mcg-50 mcg-25 mcg/0.5 mL intramuscular syringe
- Inject 0.5 milliliter by intramuscular route once
Meningococcal vaccination
- Inject 0.5 milliliter by intramuscular route once
- None
Contraindicated
- fingolimod
- Gilenya
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- High fever >101 degrees fahrenheit
BEXSERO (MENINGOCOCCAL GROUP B VACCINE, 4-COMPONENT)
- Meningococcal vaccination
- None
- Anorexia
- Arthralgias
- Dizziness
- Erythema
- Headache disorder
- Induration of skin
- Injection site sequelae
- Malaise
- Myalgias
- Nausea
- Pain
More Frequent
Severe
Less Severe
- None
- Diarrhea
- Drowsy
- Fever
- Irritability
- Skin rash
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Meningococcal Group B Vaccine
No safety and efficacy age < 10 years.
- 1 Day – 10 Years
- No safety and efficacy age < 10 years.
Meningoccocal Grp B Vac, Recom
- Severity Level:
2
- Additional Notes: Insufficient human data avail; consider maternal treatment benefits
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Meningoccocal Group B Vaccine
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Meningococcal vaccination | |
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z23 | Encounter for immunization |
| 0-9 | A-Z |
|---|---|
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z23 | Encounter for immunization |
Formulary Reference Tool